The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | S | Sensory organs | |
| 2 | S01 | Ophthalmologicals | |
| 3 | S01F | Mydriatics and cycloplegics | |
| 4 | S01FB | Sympathomimetics excl. antiglaucoma preparations | |
| 5 | S01FB01 | Phenylephrine |
| Active Ingredient | Description | |
|---|---|---|
| Phenylephrine |
Phenylephrine is a sympathomimetic agent with mainly direct effects on adrenergic receptors. It has predominantly alpha adrenergic activity and is without stimulating effects on the central nervous system. The sympathomimetic effect of phenylephrine produces vasoconstriction which in turn relieves nasal congestion. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| MYDFRIN 2.5% w/v Ophthalmic solution | Health Products and Food Branch (CA) | MPI, CA: SPM | |
| PHENYLEPHRINE Injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
